 | Up a level |
Journal Article
Behringer, K., Oertel, M., Rueffer, J. U. and Borchmann, P. (2022). Disease- and treatment-related late sequelae in Hodgkin lymphoma. Onkologie, 28 (10). S. 914 - 923. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2731-7234
Channaoui, M., Oertel, M., Kroeger, K., Baues, C., Haverkamp, U. and Eich, H. T. (2020). Investigation of the Dose Parameters as a Part of the Quality Assurance for the Hodgkin Study (HD17) and its Consequences on the Tumor Control Rate and the Rate of Side Effects. Strahlenther. Onkol., 196 (SUPPL 1). S. S166 - 1. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X
Ferdinandus, J., Oertel, M., Eichenauer, D. A., Meissner, J., Engert, A. and Borchmann, P. (2022). Advanced-stage Hodgkin lymphoma. Onkologie, 28 (10). S. 889 - 901. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2731-7234
Kriz, J., Baues, C., Oertel, M., Engenhart-Cabillic, R., Herfarth, K., Lukas, P., Marnitz-Schulze, S., Schmidberger, H., Vordermark, D., Haverkamp, U., Engert, A. and Eich, H. (2018). First Results of Quality Control of Involved Node Radiotherapy within the HD17-Study of the German Hodgkin Study Group (GHSG). Strahlenther. Onkol., 194. S. S14 - 1. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X
Oertel, M., Elsayad, K., Engenhart-Cabillic, R., Reinartz, G., Baues, C., Schmidberger, H., Vordermark, D., Marnitz, S., Lukas, P., Ruebe, C., Engert, A., Lenz, G. and Eich, H. T. (2020). Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic Expert recommendations from the radiation oncology panels of the German Hodgkin Study Group and the German Lymphoma Alliance. Strahlenther. Onkol., 196 (12). S. 1096 - 1103. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X
Oertel, M., Linde, P., Maeurer, M., Fleischmann, D. F., Dietzel, C. T. and Krug, D. (2020). Quality of teaching radiation oncology in Germany-Where do we stand? Results from a 2019 survey performed by the working group young DEGRO of the German Society of Radiation Oncology (DEGRO). Strahlenther. Onkol., 196 (SUPPL 1). S. S198 - 2. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X
Oertel, M., Linde, P., Maeurer, M., Fleischmann, D. F., Dietzel, C. T. and Krug, D. (2020). Quality of teaching radiation oncology in Germany-where do we stand? Results from a 2019 survey performed by the working group young DEGRO of the German Society of Radiation Oncology. Strahlenther. Onkol., 196 (8). S. 699 - 705. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X
Ostheimer, C., Baues, C., Baumann, R., Billiet, C., Dobiasch, S., Ebert, N., Fleischmann, D., Gauer, T., Goy, Y., Haussmann, J., Henkenberens, C., Kaessmann, L., Lopez Guerra, J., Kaul, D., Krug, D., Maeurer, M., Niyazi, M., Oertel, M., Panje, C., Sautter, L., Schmitt, D., Suess, C., Trommer-Nestler, M., Ziegler, S. and Medenwald, D. (2018). Predictive value of GTV in radiotherapy of NSCLC - early results of the NCT03055715 trial. Radiother. Oncol., 127. S. S175 - 1. CLARE: ELSEVIER IRELAND LTD. ISSN 1879-0887
Ostheimer, C., Baues, C., Baumann, R., Billiet, C., Dobiasch, S., Ebert, N., Fleischmann, D. F., Gauer, T., Giordano, F., Goy, Y., Hausmann, J., Henkenberens, C., Kaesmann, L., Guerra, Lopez J. L., Kaul, D., Krug, D., M, Maeurer, Niyazi, M., Oertel, M., Panje, C. M., Pyschny, F., Schmitt, D., Sautter, L., Suess, C., Thieme, A. H., Trommer-Nestler, M., Ziegler, S. and Medenwald, D. (2018). Acute toxicity in the radical radiotherapy of advanced NSCLC-results of the NCT03055715 trial of the yDEGRO Trial Group. Strahlenther. Onkol., 194. S. S139 - 2. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X
Ostheimer, C., Baues, C., Baumann, R., Billiet, C., Dobiasch, S., Ebert, N., Fleischmann, D. F., Gauer, T., Giordano, F., Goy, Y., Hausmann, J., Henkenberens, C., Kaesmann, L., Guerra, Lopez J. L., Kaul, D., Krug, D., Maeurer, M., Niyazi, M., Oertel, M., Panje, C. M., Pyschny, F., Schmitt, D., Sautter, L., Suess, C., Thieme, A. H., Trommer-Nestler, M., Ziegler, S. and Medenwald, D. (2018). Prognostic and predictive value of GTV in the radical radiotherapy of advanced NSCLC-early results of the NCT03055715 trial of the yDEGRO Trial Group. Strahlenther. Onkol., 194. S. S23 - 1. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X
Ostheimer, C., Baues, C., Baumann, R., Dobiasch, S., Eze, C., Fleischmann, D., Gauer, T., Giordano, F. A., Goy, Y., Hausmann, J., Henkenberens, C., Kaul, D. P., Kloock, L., Krug, D., Kaesmann, L., Niyazi, K-M., Maeurer, M., Oertel, M., Panje, C., Rosenbrock, J., Sautter, L., Schmitt, D., Suess, C., Thieme, A. H., Trommer-Nestler, M., Ziegler, S., Ebert, N. and Medenwald, D. (2018). Prognostic relevance of tumor volume and its changes in the radical radiotherapy of advanced NSCLC - a multicenter retrospective evaluation of the working group young DEGRO of the German Society of Radiation Oncology (DEGRO). Oncol. Res. Treat., 41. S. 106 - 107. BASEL: KARGER. ISSN 2296-5262
Ostheimer, C., Maeurer, M., Ebert, N., Schmitt, D., Krug, D., Baumann, R., Henkenberens, C., Giordano, F. A., Sautter, L., Lopez, Guerra, Fleischmann, D. F., Niyazi, M., Kaesmann, L., Kaul, D., Thieme, A. H., Billiet, C., Dobiasch, S., Arnold, C. R., Oertel, M., Haussmann, J., Gauer, T., Goy, Y., Suess, C., Ziegler, S., Panje, C. M., Baues, C., Trommer, M., Skripcak, T. and Medenwald, D. (2021). Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group (Jan, 10.1007/s00066-020-01727-4, 2021). Strahlenther. Onkol., 197 (6). S. 560 - 562. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X
Ostheimer, C., Maeurer, M., Ebert, N., Schmitt, D., Krug, D., Baumann, R., Henkenberens, C., Giordano, F. A., Sautter, L., Lopez, Guerra, Fleischmann, D. F., Niyazi, M., Kasmann, L., Kaul, D., Thieme, A. H., Billiet, C., Dobiasch, S., Arnold, C. R., Oertel, M., Haussmann, J., Gauer, T., Goy, Y., Suess, C., Ziegler, S., Panje, C. M., Baues, C., Trommer-Nestler, M., Skripcak, T. and Medenwald, D. (2021). Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group. Strahlenther. Onkol., 197 (5). S. 385 - 396. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X